Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Divalproex DR · 2 trials · 2 indications
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Divalproex Sodium 500 mg DR Tablets (Sandoz Inc., USA) |
| 2 | ACTIVE_COMPARATOR | Depakote 500 mg DR Tablets (Abbott Laboratories, USA) |
| Name | Type | Description |
|---|---|---|
| Divalproex Sodium 500 mg DR Tablets (Sandoz Inc., USA) | DRUG | - |
| Depakote 500 mg DR Tablets (Abbott Laboratories, USA) | DRUG | - |
Inclusion Criteria: * No clinically significant abnormal finding on physical exam, medical history, or clinical laboratory results on screening. Exclusion Criteria: * Positive test results for HIV or hepatitis B or C. * Treatment for drug or alcohol dependence.